Microport Cardioflow Medtech
MicroPort CardioFlow Medtech Corporation is a medical device enterprise headquartered in Shanghai, China. The firm develops, manufactures, and markets structural heart disease medical devices and transcatheter heart valve technologies. Its principal offerings comprise transcatheter aortic valve implantation systems, balloon catheters, loading systems, and related accessory tools. Revenue is derived primarily from the sale of interventional medical devices to hospitals, cardiac centers, and medical distributors. The business serves interventional cardiologists and surgical teams operating across mainland China and emerging international markets. MicroPort CardioFlow Medtech Corporation is publicly traded on the Hong Kong Stock Exchange.
5 of the funds FundTelligence covers report a position in Microport Cardioflow Medtech.
- Legal name
- Microport Cardioflow Medtech Corp
- Sector
- Health Care
- Country
- China
- Funds holding it
- 5
Funds holding Microport Cardioflow Medtech
- Storebrand Global Indeks — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Indeks Alle Markeder — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Indeks Nye Markeder — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Global All Countries — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Emerging Markets — Storebrand · 0.0 % (full portfolio disclosed, October 2026)